Related Experiment Video
Updated: Oct 30, 2025

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
Published on: December 8, 2017
Homocysteine and Age-Related Central Nervous System Diseases: Role of Inflammation
Amany Tawfik1,2,3,4,5, Nehal M Elsherbiny1,2,6, Yusra Zaidi1,2
1Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, Augusta, GA 30912, USA.
Insights
High homocysteine levels (HHcy) are common in older adults and linked to neurodegenerative diseases like Alzheimer's (AD) and eye conditions. Inflammation disrupts blood-brain and blood-retinal barriers, contributing to these HHcy-related aging diseases.
Area of Science:
- Neuroscience
- Ophthalmology
- Gerontology
Background:
- Hyperhomocysteinemia (HHcy) is prevalent in the aging population.
- HHcy is associated with neurodegenerative diseases like Alzheimer's disease (AD) and ocular conditions such as age-related macular degeneration (AMD) and diabetic retinopathy (DR).
- Disruption of blood-brain and blood-retinal barrier integrity is a key mechanism in HHcy-related disorders.
Purpose of the Study:
- To review the role of inflammation in HHcy-induced barrier dysfunction.
- To explore the link between HHcy, barrier impairment, and neurovascular injury in aging diseases.
- To focus on the implications for Alzheimer's disease (AD).
Main Methods:
- Literature review of studies on HHcy, neurodegenerative diseases, and eye diseases.
- Analysis of mechanisms underlying blood-brain and blood-retinal barrier disruption.
- Examination of the role of inflammation in HHcy-associated pathology.
Main Results:
- HHcy contributes to neurodegenerative and retinal disorders by impairing barrier function.
- Impaired barrier function triggers inflammatory responses, exacerbating disease.
- AD patients frequently exhibit visual impairments, suggesting retinal involvement.
Conclusions:
- Inflammation is a likely mechanism driving HHcy-induced barrier dysfunction and neurovascular injury in aging.
- The retina may be a significant site for AD pathology, linked to HHcy.
- Targeting inflammation could be crucial for managing HHcy-related aging diseases.
Abstract:
Hyperhomocysteinemia (HHcy) is remarkably common among the aging population. The relation between HHcy and the development of neurodegenerative diseases, such as Alzheimer's disease (AD) and eye diseases, and age-related macular degeneration (AMD) and diabetic retinopathy (DR) in elderly people, has been established. Disruption of the blood barrier function of the brain and retina is one of the most important underlying mechanisms associated with HHcy-induced neurodegenerative and retinal disorders. Impairment of the barrier function triggers inflammatory events that worsen disease pathology. Studies have shown that AD patients also suffer from visual impairments. As an extension of the central nervous system, the retina has been suggested as a prominent site of AD pathology. This review highlights inflammation as a possible underlying mechanism of HHcy-induced barrier dysfunction and neurovascular injury in aging diseases accompanied by HHcy, focusing on AD.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Inflammation
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

